Ignite Creation Date:
2025-12-24 @ 9:23 PM
Ignite Modification Date:
2026-01-29 @ 6:20 AM
Study NCT ID:
NCT00282932
Status:
COMPLETED
Last Update Posted:
2021-01-27
First Post:
2006-01-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Detrol LA In Men With Overactive Bladder.
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Overactive Bladder (OAB) | View |
Keywords: